Edition:
United States

Sartorius AG (SATG.F)

SATG.F on Frankfurt Stock Exchange

82.00EUR
23 May 2017
Change (% chg)

€-1.06 (-1.28%)
Prev Close
€83.06
Open
€82.00
Day's High
€82.00
Day's Low
€82.00
Volume
0
Avg. Vol
395
52-wk High
€83.28
52-wk Low
€57.01

SATG.F

Chart for SATG.F

About

Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates through two segments: Bioprocess Solutions and Lab Products and Services. The Bioprocess Solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media,... (more)

Overall

Beta: -0.27
Market Cap(Mil.): €6,341.72
Shares Outstanding(Mil.): 74.88
Dividend: 0.45
Yield (%): 0.55

Financials

  SATG.F Industry Sector
P/E (TTM): 54.10 44.54 17.29
EPS (TTM): 1.54 -- --
ROI: 11.86 7.70 -5.84
ROE: 18.40 12.65 -5.23

BRIEF-Sartorius affirms 2017 guidance as Q1 beats consensus

* Says increased its underlying EBITDA by 17.0% to 84.6 million euros, and its respective margin from 24.0% to 24.7%

Apr 24 2017

BRIEF-Sartorius acquires Essen BioScience for $320 mln in cash

* Sartorius to acquire real-time live-cell analysis pioneer and leader Essen BioScience

Mar 03 2017

BRIEF-Sartorius FY earnings increase by nearly one-fourth to EUR 324.5 mln

* Outlook for 2017: sales growth of 8 percent to 12 percent planned; profitability projected to further increase

Feb 23 2017

BRIEF-Sartorius appoints Reiner Lehmann chief financial officer

* Dividends to increase to 0.46 euros ($0.4850) per preference share and to 0.45 euros per ordinary share

Feb 21 2017

More From Around the Web

Earnings vs. Estimates